BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33135866)

  • 1. Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma.
    Dizman N; Hsu J; Bergerot PG; Gillece JD; Folkerts M; Reining L; Trent J; Highlander SK; Pal SK
    Cancer Med; 2021 Jan; 10(1):79-86. PubMed ID: 33135866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Bifidobacterium animalis Subsp. Lactis (B. lactis) Strain BB-12-Supplemented Yogurt in Healthy Children.
    Tan TP; Ba Z; Sanders ME; D'Amico FJ; Roberts RF; Smith KH; Merenstein DJ
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):302-309. PubMed ID: 28114246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics (PLAY ON).
    Merenstein D; Sparenborg J; Tan T; D'Amico F; Kumar A; Herbin Smith K
    Ann Fam Med; 2024 Nov; 21(Suppl 3):. PubMed ID: 38271203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Yogurt Enriched with Platelet-Activating Factor Inhibitors from Olive Oil By-Products Affect Gut Microbiota and Faecal Metabolites in Healthy Overweight Subjects? (A randomized, parallel, three arm trial.).
    Antonopoulou S; Mitsou EK; Kyriacou A; Fragopoulou E; Detopoulou M
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):159. PubMed ID: 38682205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Habitual Intake of Probiotic Supplements and Yogurt with Characteristics of the Gut Microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
    Chai W; Maskarinec G; Lim U; Boushey CJ; Wilkens LR; Setiawan VW; Le Marchand L; Randolph TW; Jenkins IC; Lampe JW; Hullar MAJ
    Gut Microbiome (Camb); 2023; 4():. PubMed ID: 38468639
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ojima MN; Gotoh A; Takada H; Odamaki T; Xiao JZ; Katoh T; Katayama T
    Front Microbiol; 2020; 11():1349. PubMed ID: 32625197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Applications of the Gut Microbiome in Genitourinary Cancers.
    Nguyen CB; Vaishampayan UN
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e100041. PubMed ID: 38788173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gut microbiome on serotonin metabolism: a personalized treatment approach.
    Potter K; Gayle EJ; Deb S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2589-2602. PubMed ID: 37922012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-specific alterations in gut microbiome and host immune responses elicited by tolerogenic Bifidobacterium pseudolongum.
    Ma B; Gavzy SJ; Saxena V; Song Y; Piao W; Lwin HW; Lakhan R; Iyyathurai J; Li L; France M; Paluskievicz C; Shirkey MW; Hittle L; Munawwar A; Mongodin EF; Bromberg JS
    Sci Rep; 2023 Jan; 13(1):1023. PubMed ID: 36658194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety assessment of probiotics for human use.
    Sanders ME; Akkermans LM; Haller D; Hammerman C; Heimbach J; Hörmannsperger G; Huys G; Levy DD; Lutgendorff F; Mack D; Phothirath P; Solano-Aguilar G; Vaughan E
    Gut Microbes; 2010; 1(3):164-85. PubMed ID: 21327023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut bacteria break down cholesterol - hinting at probiotic treatments.
    Nowogrodzki J
    Nature; 2024 Apr; ():. PubMed ID: 38565909
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors.
    Chahoud J; Msaouel P; Ross JA; McCormick BZ; Bathala TK; Gao J; Horn R; Xiao L; Sircar K; Campbell MT; Shah AY; Goswami S; Zurita AJ; Jonasch E; Matin SF; Wood CG; Karam JA; Sharma P; Tannir NM
    Urol Oncol; 2021 Feb; 39(2):134.e9-134.e16. PubMed ID: 33187886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
    Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics for pain of osteoarthritis; An N-of-1 trial of individual effects.
    Taye I; Bradbury J; Grace S; Avila C
    Complement Ther Med; 2020 Nov; 54():102548. PubMed ID: 33183666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolution of Angiogenic and Inflamed Tumors: The Renal Cancer Paradigm.
    Brugarolas J; Rajaram S; Christie A; Kapur P
    Cancer Cell; 2020 Dec; 38(6):771-773. PubMed ID: 33157049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intestinal flora on immune checkpoint inhibitors in tumor treatment: a narrative review.
    Wang D; Hao H; Li X; Wang Z
    Ann Transl Med; 2020 Sep; 8(17):1097. PubMed ID: 33145316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.
    Do OA; Ferris LA; Holt SK; Ramos JD; Harshman LC; Plimack ER; Crabb SJ; Pal SK; De Giorgi U; Ladoire S; Baniel J; Necchi A; Vaishampayan UN; Bamias A; Bellmunt J; Srinivas S; Dorff TB; Galsky MD; Yu EY
    Clin Genitourin Cancer; 2021 Apr; 19(2):125-134. PubMed ID: 33309564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E
    Crittenden S; Goepp M; Pollock J; Robb CT; Smyth DJ; Zhou Y; Andrews R; Tyrrell V; Gkikas K; Adima A; O'Connor RA; Davies L; Li XF; Yao HX; Ho GT; Zheng X; Mair A; Vermeren S; Qian BZ; Mole DJ; Gerasimidis K; Schwarze JKJ; Breyer RM; Arends MJ; O'Donnell VB; Iredale JP; Anderton SM; Narumiya S; Maizels RM; Rossi AG; Howie SE; Yao C
    Sci Adv; 2021 Feb; 7(7):. PubMed ID: 33579710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.
    Pal SK; Tangen C; Thompson IM; Balzer-Haas N; George DJ; Heng DYC; Shuch B; Stein M; Tretiakova M; Humphrey P; Adeniran A; Narayan V; Bjarnason GA; Vaishampayan U; Alva A; Zhang T; Cole S; Plets M; Wright J; Lara PN
    Lancet; 2021 Feb; 397(10275):695-703. PubMed ID: 33592176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
    Desai A; Gainor JF; Hegde A; Schram AM; Curigliano G; Pal S; Liu SV; Halmos B; Groisberg R; Grande E; Dragovich T; Matrana M; Agarwal N; Chawla S; Kato S; Morgan G; Kasi PM; Solomon B; Loong HH; Park H; Choueiri TK; Subbiah IM; Pemmaraju N; Subbiah V;
    Nat Rev Clin Oncol; 2021 May; 18(5):320. PubMed ID: 33758378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.